Risk factors for severe adverse drug reactions in hospitalized patients

被引:0
|
作者
Petrovic, Nemanja Z. [1 ,2 ]
Pejcic, Ana V. [1 ]
Milosavljevic, Milos N. [1 ]
Jankovic, Slobodan M. [1 ,2 ]
机构
[1] Univ Kragujevac, Fac Med Sci, Dept Pharmacol & Toxicol, Svetozara Markovica 69, Kragujevac 34000, Serbia
[2] Univ Clin Ctr Kragujevac, Dept Clin Pharmacol, Kragujevac 34000, Serbia
来源
OPEN MEDICINE | 2025年 / 20卷 / 01期
关键词
severe adverse drug reactions; risk factors; drugs; polypharmacy; OUTCOMES;
D O I
10.1515/med-2024-1122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Severe adverse drug reactions (sADRs) are becoming increasingly common nowadays. The incidence of sADRs is approaching 6.7%, and the incidence of fatal adverse reactions is 0.32% in hospitalized patients. Of these, 48.5% are, at least potentially, preventable.Aims This study's objective was to determine factors associated with the occurrence and preventability of sADRs occurring at the tertiary level.Methods A case-control retrospective-prospective clinical observational study design was used for the study. The research cohort included patients hospitalized at the University Clinical Center (UCC) in Kragujevac, Serbia, from January 1, 2019 to January 1, 2024. The research comprised 147 individuals who were admitted to the UCC in Kragujevac. There were 49 patients with sADRs and 98 controls.Results Significant factors associated with sADRs in our study were a total number of consultations (ORadjusted = 5.60), Charlson comorbidity index (ORadjusted = 0.30), C-reactive protein (ORadjusted = 1.07), prescribed antihistamines (ORadjusted = 14.37), and antihypertensives (ORadjusted = 0.15).Conclusion We have identified the factors that are associated with sADRs should be kept in mind while working with patients at the tertiary level. Early detection of those factors may help with early notification of sADRs and their prevention.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Adverse Drug Reactions in Patients with CKD
    Laville, Solene M.
    Gras-Champel, Valerie
    Moragny, Julien
    Metzger, Marie
    Jacquelinet, Christian
    Combe, Christian
    Fouque, Denis
    Laville, Maurice
    Frimat, Luc
    Robinson, Bruce M.
    Stengel, Benedicte
    Massy, Ziad A.
    Liabeuf, Sophie
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (08): : 1090 - 1102
  • [32] Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
    Cahir, Caitriona
    Curran, Carmel
    Walsh, Caroline
    Hickey, Anne
    Brannigan, Ross
    Kirke, Ciara
    Williams, David J.
    Bennett, Kathleen
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [33] Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population
    Saksit, Niwat
    Tassaneeyakul, Wichittra
    Nakkam, Nontaya
    Konyoung, Parinya
    Khunarkornsiri, Usanee
    Chumworathayi, Pansu
    Sukasem, Chonlaphat
    Suttisai, Sumitra
    Piriyachananusorn, Napacha
    Tiwong, Pawinee
    Chaiyakunapruk, Nathorn
    Sawanyawisuth, Kittisak
    Rerkpattanapipat, Ticha
    Tassaneeyakul, Wongwiwat
    PHARMACOGENETICS AND GENOMICS, 2017, 27 (07) : 255 - 263
  • [34] Heart Failure and Adverse Drug Reactions Among Hospitalized Older Adults
    Catananti, C.
    Liperoti, R.
    Settanni, S.
    Lattanzio, F.
    Bernabei, R.
    Fialova, D.
    Landi, F.
    Onder, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (03) : 307 - 310
  • [35] Drug safety in hospitalized patients with tuberculosis: Drug interactions and adverse drug effects
    Noor, Sidra
    Ismail, Mohammad
    Khan, Fahadullah
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (01) : 97 - 108
  • [36] Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study
    Asia N. Rashed
    Ian C. K. Wong
    Noel Cranswick
    Stephen Tomlin
    Wolfgang Rascher
    Antje Neubert
    European Journal of Clinical Pharmacology, 2012, 68 : 801 - 810
  • [37] Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study
    Rashed, Asia N.
    Wong, Ian C. K.
    Cranswick, Noel
    Tomlin, Stephen
    Rascher, Wolfgang
    Neubert, Antje
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 801 - 810
  • [38] Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial
    O'Mahony, Denis
    Gudmundsson, Adalsteinn
    Soiza, Roy L.
    Petrovic, Mirko
    Jose Cruz-Jentoft, Alfonso
    Cherubini, Antonio
    Fordham, Richard
    Byrne, Stephen
    Dahly, Darren
    Gallagher, Paul
    Lavan, Amanda
    Curtin, Denis
    Dalton, Kieran
    Cullinan, Shane
    Flanagan, Evelyn
    Shiely, Frances
    Samuelsson, Olafur
    Sverrisdottir, Astros
    Subbarayan, Selvarani
    Vandaele, Lore
    Meireson, Eline
    Montero-Errasquin, Beatriz
    Rexach-Cano, Aurora
    Correa Perez, Andrea
    Lozano-Montoya, Isabel
    Velez-Diaz-Pallares, Manuel
    Cerenzia, Annarita
    Corradi, Samanta
    Ferreiro, Maria Soledad Cotorruelo
    Dimitri, Federica
    Marinelli, Paolo
    Martelli, Gaia
    Khioe, Rebekah Fong Soe
    Eustace, Joseph
    AGE AND AGEING, 2020, 49 (04) : 605 - 614
  • [39] Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission
    Consuelo Pedrós
    Beatriz Quintana
    Mireia Rebolledo
    Núria Porta
    Antoni Vallano
    Josep Maria Arnau
    European Journal of Clinical Pharmacology, 2014, 70 : 361 - 367
  • [40] Acute muscle loss in elderly hospitalized patients: Risk factors and adverse clinical outcomes
    Liu, Jia
    Xue, Heng
    Ma, Yi-han
    Wang, Zheng
    GERIATRIC NURSING, 2025, 61 : 449 - 454